These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 29976833)

  • 41. Cortical Gray Matter MR Imaging in Multiple Sclerosis.
    Calabrese M; Castellaro M
    Neuroimaging Clin N Am; 2017 May; 27(2):301-312. PubMed ID: 28391788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.
    Fuchs TA; Dwyer MG; Kuceyeski A; Choudhery S; Carolus K; Li X; Mallory M; Weinstock-Guttman B; Jakimovski D; Ramasamy D; Zivadinov R; Benedict RHB
    Hum Brain Mapp; 2018 Sep; 39(9):3682-3690. PubMed ID: 29740964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential white and gray matter damage in highly active multiple sclerosis: A prospective cohort study.
    Pappolla A; Sánchez F; Caro F; Miguez J; Patrucco L; Cristiano E; Rojas JI
    J Clin Neurosci; 2020 Apr; 74():65-68. PubMed ID: 32001112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M; Lotze M; Langner S; Dressel A
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
    Cortese R; Battaglini M; Parodi F; Stromillo ML; Portaccio E; Razzolini L; Giorgio A; Sormani MP; Amato MP; De Stefano N
    Mult Scler; 2022 Jan; 28(1):154-159. PubMed ID: 34100326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating the effects of white matter multiple sclerosis lesions on the volume estimation of 6 brain tissue segmentation methods.
    Valverde S; Oliver A; Díez Y; Cabezas M; Vilanova JC; Ramió-Torrentà L; Rovira À; Lladó X
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1109-15. PubMed ID: 25678478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging.
    Raz E; Cercignani M; Sbardella E; Totaro P; Pozzilli C; Bozzali M; Pantano P
    Radiology; 2010 Nov; 257(2):448-54. PubMed ID: 20858849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
    Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.
    Roostaei T; Sadaghiani S; Mashhadi R; Falahatian M; Mohamadi E; Javadian N; Nazeri A; Doosti R; Naser Moghadasi A; Owji M; Hashemi Taheri AP; Shakouri Rad A; Azimi A; Voineskos AN; Nazeri A; Sahraian MA
    Mult Scler; 2019 Apr; 25(4):532-540. PubMed ID: 29485352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
    Koskimäki F; Bernard J; Yong J; Arndt N; Carroll T; Lee SK; Reder AT; Javed A
    PLoS One; 2018; 13(12):e0209326. PubMed ID: 30576361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira A; Sastre-Garriga J; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Filippi M;
    Neurology; 2021 Mar; 96(11):e1561-e1573. PubMed ID: 33441452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asymptomatic carotid stenosis is associated with gray and white matter damage.
    Avelar WM; D'Abreu A; Coan AC; Lima FO; Guimarães R; Yassuda CL; Oliveira GP; Guillaumon AT; Filho AA; Min LL; Cendes F
    Int J Stroke; 2015 Dec; 10(8):1197-203. PubMed ID: 26235564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic gray matter volume changes in pediatric multiple sclerosis: A 3.5 year MRI study.
    De Meo E; Meani A; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
    Neurology; 2019 Apr; 92(15):e1709-e1723. PubMed ID: 30867274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis.
    Jakimovski D; Zivadinov R; Bergsland N; Ramasamy DP; Hagemeier J; Weinstock-Guttman B; Kolb C; Hojnacki D; Dwyer MG
    J Neuroimaging; 2020 May; 30(3):342-350. PubMed ID: 32392376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.